16-30667571-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001105079.3(FBRS):c.2023A>G(p.Thr675Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,542,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001105079.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 151862Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000309 AC: 46AN: 148758Hom.: 0 AF XY: 0.000294 AC XY: 23AN XY: 78338
GnomAD4 exome AF: 0.000123 AC: 171AN: 1390866Hom.: 0 Cov.: 32 AF XY: 0.000125 AC XY: 86AN XY: 685906
GnomAD4 genome AF: 0.000263 AC: 40AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.463A>G (p.T155A) alteration is located in exon 9 (coding exon 8) of the FBRS gene. This alteration results from a A to G substitution at nucleotide position 463, causing the threonine (T) at amino acid position 155 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at